Pharma Giant Sees Six-Fold Boost in Awareness of New Myeloid Disease Treatment With CMK Select by CMK SELECT CMK SELECT CMK SELECT
CMK SELECT CMK SELECT CMK SELECT
The Challenge Within hematology, Higher Risk-Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia (AML) are diseases with a highly unmet treatment need. In response, an NJ-based pharmaceutical leader created an innovative new immune-modulating treatment that shows tremendous promise in the fight against myeloid disease. While the new regimen offered an effective immunotherapeutic approach that addresses the
CMK SELECT
43 Route 46 East, Suite 705 Pine Brook, NJ 07058 USA
Rachel Phone: (973) 244-6060

FORGOT YOUR DETAILS?

Pharma Giant Sees Six-Fold Boost in Awareness of New Myeloid Disease Treatment With CMK Select

by CMK SELECT / /
four people gathered around a conference table

The Challenge

Within hematology, Higher Risk-Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia (AML) are diseases with a highly unmet treatment need. In response, an NJ-based pharmaceutical leader created an innovative new immune-modulating treatment that shows tremendous promise in the fight against myeloid disease.

While the new regimen offered an effective immunotherapeutic approach that addresses the lack of durable response in myeloid disease, aided and unaided awareness of the treatment among practitioners was very low—around 10%. The pharma giant turned to CMK to create a program designed to drive awareness and generate excitement about the new drug in advance of its launch.

The Solution

CMK implemented a multi-pronged Disease Awareness Campaign aimed at delivering key messages to practitioners through multiple channels. They created a highly engaging website to house all pertinent information about the disease itself, treatment limitations and the drug’s mechanism in the body, followed by a robust media campaign that included banner ads, emails, paid search, videos and social media marketing.

The Results

Within six months, awareness soared to 60%, with total hits to the site approaching 20K. Today, the client is on pace to reach its goal of 80 – 100% aided awareness by the end of the year for what is expected to become the cornerstone of treatment for MDS/AML.

Leave a Reply

Your email address will not be published. Required fields are marked *

Share on:

... KNOWLEDGE & INSIGHTS

CMK SELECT

CMK Brings Order to Pharma Company’s Struggling Multi-Product, Multi-Release Launch

AUTHOR: CMK SELECT

A privately owned, rapidly growing pharmaceutical company was charged with rolling out 22 releases for a multi-product launch in one year’s time. In the early stages of the program, the client struggled with a series of issues that,…
CONTINUE READING
CMK SELECT

CMK Helps Global Pharmaceutical Leader Streamline Processes and Protocols to Meet Government Requirements and Deliver Ongoing Operational Efficiencies

AUTHOR: CMK SELECT

The U.S. cardiovascular team of a global pharmaceutical company needed help responding to a new Corporate Integrity Agreement for two launch products. Resource-constrained at the time, they were looking for a streamlined and efficient way to satisfy the…
CONTINUE READING

LIKE OUR PAGE

FOLLOW US

GET LINKED IN

TOP